SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

Novo Nordisk: GLP-1 Pill Preferred

Novo Nordisk's US Chief reports twice as many Medicare patients prefer GLP-1 pill to shot

NVO

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.